Cargando…
Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years
Among patients with non-small-cell lung cancer (NSCLC), those with pathological stage I have the best expectation of survival; however, survival is reduced to less than 50% in the long term. At present, it is unclear when patients can be reasonably defined as cured, and if they experience a higher i...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377134/ https://www.ncbi.nlm.nih.gov/pubmed/12771977 http://dx.doi.org/10.1038/sj.bjc.6600991 |